Litigation Details for VIFOR (INTERNATIONAL) AG v. SANDOZ INC. (D.N.J. 2019)
✉ Email this page to a colleague
VIFOR (INTERNATIONAL) AG v. SANDOZ INC. (D.N.J. 2019)
| Docket | ⤷ Sign Up | Date Filed | 2019-08-02 |
| Court | District Court, D. New Jersey | Date Terminated | 2020-02-06 |
| Cause | 35:271 Patent Infringement | Assigned To | Freda L. Wolfson |
| Jury Demand | None | Referred To | Douglas Arpert |
| Patents | 7,612,109; 7,754,702; 8,895,612; 9,376,505 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in VIFOR (INTERNATIONAL) AG v. SANDOZ INC.
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for VIFOR (INTERNATIONAL) AG v. SANDOZ INC. (D.N.J. 2019)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2019-08-02 | 1 | Complaint | United States Patent Nos. 7,612,109 (“the ʼ109 patent”); 7,754,702 (“the ʼ702 patent”); 8,895,612 (“…Unenforceability, and/or Non-Infringement for U.S. Patent Nos. 7,612,109; 7,754,702; 8,895,612; 9,376,505; and Pursuant…the ʼ612 patent”); and 9,376,505 (“the ʼ505 patent”). The ’109, ’702, ’612, and ’505 patents are listed…. This is an action for patent infringement arising under the patent laws of the United States, … PATENTS-IN-SUIT 23. The U.S. Patent and Trademark Office (“PTO” | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
